Biofrontera Inc. (NASDAQ:BFRIW – Get Free Report) was the target of a large decline in short interest during the month of July. As of July 31st, there was short interest totaling 2,578 shares, a decline of 60.0% from the July 15th total of 6,447 shares. Based on an average daily volume of 5,485 shares, the short-interest ratio is presently 0.5 days.
Biofrontera Price Performance
NASDAQ:BFRIW remained flat at $0.02 during mid-day trading on Friday. The company had a trading volume of 30,328 shares, compared to its average volume of 6,234. The firm’s 50 day moving average price is $0.03 and its 200 day moving average price is $0.04. Biofrontera has a 1 year low of $0.02 and a 1 year high of $0.15.
About Biofrontera
Biofrontera AG is a biopharmaceutical company headquartered in Leverkusen, Germany, specializing in the development, manufacture and commercialization of dermatology products. Founded in 1997, the company focuses on therapies for skin diseases through innovative drug and device combinations. Its core business centers on photodynamic therapy, where a photosensitizing agent is activated by a specialized light source to treat precancerous and cancerous skin conditions.
The company’s flagship product, Ameluz, is a topical formulation of aminolevulinic acid used in conjunction with the BF-RhodoLED irradiation device.
Recommended Stories
- Five stocks we like better than Biofrontera
- OneSpaWorld Keeps Turning Cruise Demand Into Record Earnings
- Meta and Tesla Are Rebounding From Oversold Levels—Now What?
- AMG’s Alternatives Boom Powers Record Growth
- Microsoft’s Maia 300 Chip Targets NVIDIA’s AI Dominance
Receive News & Ratings for Biofrontera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biofrontera and related companies with MarketBeat.com's FREE daily email newsletter.
